SIOGEN Biotech voted ‘Most Innovative Biotech in Asia’ at BioPharma Industry Awards 2011
SIOGEN Biotech has been awarded the ‘Most Innovative Biotech in Asia Award’ for 2011. Presented at the BioPharma Industry Asia Awards in Singapore, held in conjunction with the 4th Annual BioPharma Asia Convention, the award recognises SIOGEN’s state of the art drug targeting and delivery technology Siosomes® and potential impact in the global pharmaceutical market.
Dr. Shermal Perera, Managing Director of SIOGEN, said, “Winning this award is further validation that Siosomes® can enable the improved, targeted delivery of a broad range of therapeutic agents. It is an exciting time for SIOGEN as our technology and creative partnering have led to a pipeline of smart therapeutics with indications in diseases ranging from tuberculosis to cancer. We are currently seeking joint venture partners and investment to set up our operations in the US, to expand our NanoVesicle technology into other markets.”
Nominations were invited from across the industry and more than 40,000 votes were cast to decide the award winners. In the ‘Most Innovative Biotech’ category, five companies were shortlisted on the basis of their innovation and novel approach in developing drugs. SIOGEN was voted the winner for its Siosomes® NanoVesicle platform technology and the creative collaborations it has established with research institutions, pharma and biotech companies worldwide.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.